HE4 Has a Role in Treatment Planning in Endometrial Cancer

被引:0
|
作者
O'Toole, Sharon
Shireen, Rizmee
McDonald, Seamus
Norris, Lucy
Cooney, Anthony
AbuSaadeh, Feras
Kamran, Waseem
Murphy, Cliona
Farah, Nadine
D'Arcy, Tom
Gleeson, Noreen
O'Leary, John J.
机构
[1] Univ Dublin Trinity Coll, Dublin 2, Ireland
[2] St James Hosp, Dublin 8, Ireland
[3] Coombe Womens & Infants Univ Hosp, Dublin, Ireland
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1191
引用
收藏
页码:300A / 300A
页数:1
相关论文
共 50 条
  • [1] HE4 Has a Role in Treatment Planning in Endometrial Cancer
    O'Toole, Sharon
    Shireen, Rizmee
    McDonald, Seamus
    Norris, Lucy
    Cooney, Anthony
    AbuSaadeh, Feras
    Kamran, Waseem
    Murphy, Cliona
    Farah, Nadine
    D'Arcy, Torn
    Gleeson, Noreen
    O'Leary, John J.
    MODERN PATHOLOGY, 2016, 29 : 300A - 300A
  • [2] HE4 HAS A ROLE IN IDENTIFYING HIGH RISK PROGNOSTIC FACTORS IN ENDOMETRIAL CANCER
    O'Toole, S.
    Foley, M.
    Rizmee, S.
    Norris, L.
    Kamran, W.
    Ibrahim, N.
    Ward, M.
    Thompson, C.
    Murphy, C.
    Anglim, M.
    D'Arcy, T.
    Farah, N.
    O'Connor, H.
    O'Leary, J.
    AbuSaadeh, F.
    Gleeson, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A351 - A352
  • [3] Role of HE4 as a biomarker for diagnostics and prognostics in endometrial cancer
    Singhal, Seema
    Chaturvedi, P.
    Ganguly, Arjun
    Jayraj, Aarthi
    Sehra, Divya
    Meena, Jyoti
    Singh, Nilanchali
    Singh, Anju
    Mathur, Sandeep
    Malhotra, Neena
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A164 - A165
  • [4] The role of novel serum biomarker HE4 in endometrial cancer
    Angioli, R.
    Capriglione, S.
    Plotti, F.
    Terranova, C.
    Oronzi, I.
    Cafa, E.
    Montone, E.
    Gennari, P.
    Linciano, F.
    Benedetti-Panici, P.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S148 - S148
  • [5] HE4 as a Biomarker for Endometrial Cancer
    Behrouzi, Roya
    Barr, Chloe E.
    Crosbie, Emma J.
    CANCERS, 2021, 13 (19)
  • [6] HE4 Levels in Endometrial Cancer Patients - Potential Role as a Tumour Biomarker
    Zanotti, L.
    Bignotti, E.
    Bandiera, E.
    Calza, S.
    Ruggeri, G.
    Romani, C.
    Tassi, A. R.
    Ragnoli, M.
    Pecorelli, S.
    Ravaggi, A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S187 - S187
  • [7] HE4 as a biomarker for ovarian and endometrial cancer management
    Li, Jinping
    Dowdy, Sean
    Tipton, Tracy
    Podratz, Karl
    Lu, Wei-Guo
    Xie, Xing
    Jiang, Shi-Wen
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2009, 9 (06) : 555 - 566
  • [8] The role of novel biomarker HE4 in endometrial cancer: a case control prospective study
    Angioli, Roberto
    Plotti, Francesco
    Capriglione, Stella
    Montera, Roberto
    Damiani, Patrizio
    Ricciardi, Roberto
    Aloisi, Alessia
    Luvero, Daniela
    Cafa, Ester Valentina
    Dugo, Nella
    Angelucci, Michela
    Benedetti-Panici, Pierluigi
    TUMOR BIOLOGY, 2013, 34 (01) : 571 - 576
  • [9] The role of HE4 in differentiating benign and malignant endometrial pathology
    Gasiorowska, Emilia
    Magnowska, Magdalena
    Izycka, Natalia
    Warchol, Wojciech
    Nowak-Markwitz, Ewa
    GINEKOLOGIA POLSKA, 2016, 87 (04) : 260 - 264
  • [10] PROGNOSTIC VALUE OF SERUM HE4 LEVEL IN ENDOMETRIAL CANCER
    Rajadevan, N.
    McNally, O.
    Neesham, D.
    Richards, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 1169 - 1169